Journal article icon

Journal article

Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study

Publication status:
Accepted
Peer review status:
Peer reviewed

Actions


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Role:
Author
Expand authors...
Publisher:
Elsevier Publisher's website
Journal:
Lancet Journal website
Acceptance date:
2021-01-08
EISSN:
1474-547X
ISSN:
0140-6736
Pubs id:
1156932
Local pid:
pubs:1156932
Language:
English
Keywords:

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP